BMED.US BlackRock Future Health ETF
- Total assets
- 14.8M
- Expense ratio
- 0.80%
- Dividend yield
- 0.22%
- 1-year return
- +26.27%
- Holdings
- 52
- Since
- 2020
Fund data as reported by the issuer, updated Nov 13, 2026. Total assets are in the fund's base currency.
What does BMED.US invest in?
- Mostly US stocks (77.8%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (82.6%)
- Top 3 holdings: 17.1% of the fund
Asset allocation
- US stocks 77.8%
- Non-US stocks 14.8%
- Cash 4.8%
Top holdings
- Moderna Inc 6.01%
- Gilead Sciences Inc 5.89%
- Danaher Corporation 5.16%
- AbbVie Inc 4.76%
- Thermo Fisher Scientific Inc 4.21%
BlackRock Future Health ETF performance
Sharpe ratio 1.04- This year
- +22.27%
- 1 year
- +26.27%
- 3 years
- +19.77%
- 5 years
- +5.03%
Volatility 16.1% over 1 year and 15.1% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
BMED.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About BlackRock Future Health ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Full fund profileBlackRock Future Health ETF top holdings
44.2% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 6.01% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 5.89% |
| Danaher Corporation DHR.US | Healthcare | United States | 5.16% |
| AbbVie Inc ABBV.US | Healthcare | United States | 4.76% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 4.21% |
| Edwards Lifesciences Corp EW.US | Healthcare | United States | 3.97% |
| IQVIA Holdings Inc IQV.US | Healthcare | United States | 3.70% |
| Biogen Inc BIIB.US | Healthcare | United States | 3.69% |
| Mettler-Toledo International Inc MTD.US | Healthcare | United States | 3.63% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 3.22% |
The 10 largest of 52 holdings.
BMED.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
BMED.US regional exposure
- North America82.6%
- Europe Developed10.7%
- United Kingdom1.5%
- Africa/Middle East1.5%
- Asia Emerging1.3%
Share of the stocks in the fund.
Company size
Average market cap 72.2B- Mega cap3.9%
- Big cap46.0%
- Medium cap35.5%
- Small cap11.8%
- Micro cap1.2%
BlackRock Future Health ETF fund profile
- Fund name
- BlackRock Future Health ETF
- Ticker
- BMED.US
- Exchange
- USA Stocks
- Issuer
- BlackRock
- Index tracked
- -
- Category
- Healthcare Equity
- Inception date
- Sep 29, 2020
- Trading currency
- USD
- Expense ratio
- 0.80%
- Annual turnover
- 0.7%
About BlackRock Future Health ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.